VNRX Stock Analysis: Buy, Sell, or Hold?

VNRX - VolitionRX Limited Common Stock

IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
$0.19
-0.01 (-3.71%) ▼
5d: -7.84%
30d: -11.13%
90d: -24.28%
HOLD
LOW Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: Mar 31, 2026 TODAY

Get Alerted When VNRX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: VNRX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.

In-depth Analysis How we analyze

Valuation Analysis: VNRX is currently trading at $0.19, which is considered fair relative to its 30-day fair value range of $0.19 to $0.21.

Technical Outlook: Technically, VNRX is in a strong downtrend. Immediate support is located at $0.17, while resistance sits at $0.30. Short-term momentum is weak, with the stock down 3.7% recently.

Market Sentiment: VNRX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $2.06 (+947.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position FAIR
Fair Price Range $0.19 - $0.21
Company Quality Score 52/100 (HOLD)
Volume Confirmation MODERATE
Confidence Score 76.3%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (60/100)
  • BEARISH: Downward momentum (-3.7%)
  • BULLISH: Trading 947.8% below Wall St target ($2.06)
  • CAUTION: Recommendation downgraded due to -7.8% 5-day decline

Fair Price Analysis

30-Day Fair Range $0.19 - $0.21
Current vs Fair Value FAIR

Support & Resistance Levels

Support Level $0.17
Resistance Level $0.30
Current Trend Strong Downtrend
Technical data as of Mar 27, 2026

Fundamental Context

Forward P/E (Next Year Est.) -2.18
Wall Street Target $2.06 (+947.8%)
Revenue Growth (YoY) 32.2%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: March 30, 2026 10:27 AM ET
Data refreshes hourly during market hours. Next update: 11:27 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BSX
Boston Scientific Corp
STRONG BUY
34 analysts
$102 60 BUY
DXCM
DexCom Inc
STRONG BUY
26 analysts
$86 48 HOLD
MDT
Medtronic PLC
BUY
32 analysts
$111 58 HOLD
PODD
Insulet Corporation
STRONG BUY
23 analysts
$354 56 HOLD
EW
Edwards Lifesciences Corp
HOLD
32 analysts
$96 53 HOLD

More Analysis for VNRX

VNRX Technical Chart VNRX Price Prediction VNRX Earnings Date VNRX Investment Advisor VNRX Fair Price Analyzer VNRX Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals